首页> 美国卫生研究院文献>The Scientific World Journal >Kinetics and Mechanism Study of Competitive Inhibition of Jack-Bean Urease by Baicalin
【2h】

Kinetics and Mechanism Study of Competitive Inhibition of Jack-Bean Urease by Baicalin

机译:黄ical苷竞争抑制杰克豆脲酶的动力学及机理研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Baicalin (BA) is the principal component of Radix Scutellariae responsible for its pharmacological activity. In this study, kinetics and mechanism of inhibition by BA against jack-bean urease were investigated for its therapeutic potential. It was revealed that the IC50 of BA against jack-bean urease was 2.74 ± 0.51 mM, which was proved to be a competitive and concentration-dependent inhibition with slow-binding progress curves. The rapid formation of initial BA-urease complex with an inhibition constant of K i = 3.89 × 10−3 mM was followed by a slow isomerization into the final complex with an overall inhibition constant of K i* = 1.47 × 10−4 mM. High effectiveness of thiol protectors against BA inhibition indicated that the strategic role of the active-site sulfhydryl group of the urease was involved in the blocking process. Moreover, the inhibition of BA was proved to be reversible due to the fact that urease could be reactivated by dithiothreitol but not reactant dilution. Molecular docking assay suggested that BA made contacts with the important activating sulfhydryl group Cys-592 residues and restricted the mobility of the active-site flap. Taken together, it could be deduced that BA was a competitive inhibitor targeting thiol groups of urease in a slow-binding manner both reversibly and concentration-dependently, serving as a promising urease inhibitor for treatments on urease-related diseases.
机译:黄ical素(BA)是黄S的主要药理活性成分。在这项研究中,研究了BA对千斤顶豆脲酶的抑制作用的动力学和抑制机理。结果表明,BA对Jack-bean脲酶的IC50为2.74±0.51 mM,被证明是具有竞争性和浓度依赖性的抑制因子,具有缓慢的结合曲线。快速形成抑制常数为K i = 3.89×10 -3 mM的初始BA-脲酶复合物,然后缓慢异构化为最终抑制物,其总抑制常数为K i * = 1.47×10 −4 mM。巯基保护剂对BA抑制的高有效性表明,脲酶的活性位巯基的战略作用与阻断过程有关。而且,由于脲酶可以被二硫苏糖醇而不是反应物稀释而重新活化的事实,证明了BA的抑制是可逆的。分子对接分析表明,BA与重要的活化巯基Cys-592残基接触,并限制了活性部位瓣的移动性。两者合计,可以推断出BA是竞争性抑制剂,其以缓慢结合的方式可逆地和浓度依赖性地靶向脲酶的巯基,是用于治疗脲酶相关疾病的有希望的脲酶抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号